Table 5.
a. Univariate analysis of proposed factors associated with postoperative RHF | |||
---|---|---|---|
Variable | Unadjusted Odds Ratio |
95% Confidence Interval | p-value |
Donor: Weight (kg) | 1.4 | 0.8–2.6 | 0.24 |
Donor: Cause of death | 1.1 | 0.7–1.6 | 0.68 |
Donor: Low-dose dopamine pre-treatment | 0.3 | 0.1–0.8 | 0.02 |
Donor: High-dose dopamine pre-treatment | 0.4 | 0.1–1.4 | 0.16 |
Donor: Other inotrope pre-treatment | 1.8 | 0.6–4.9 | 0.27 |
Donor: Thyroxine pre-treatment | 0.9 | 0.4–2.0 | 0.88 |
Donor: Downtime (y/n) | 0.8 | 0.4–1.9 | 0.74 |
Donor: Abnormal echocardiogram | 0.7 | 0.2–3.6 | 0.73 |
Recipient: Admission diagnosis | 1.1 | 0.7–1.9 | 0.61 |
Recipient: Ventilator support, pre-operative | 0.6 | 0.2–2.1 | 0.43 |
Recipient: VAD placement, pre-operative | 0.6 | 0.2–2.3 | 0.48 |
Recipient: ECMO, pre-operative | 1.6 | 0.4–6.3 | 0.50 |
Recipient: High-dose/Multiple Inotropes | 1.8 | 0.8–4.3 | 0.17 |
Recipient: Status 1A, prior to transplant | 1.8 | 0.6–5.4 | 0.32 |
Recipient: PVRi, pre-operative | 1.2 | 1.1–1.4 | 0.006 |
Graft cold ischemic time (mins) | 1.0 | 0.9–1.1 | 0.55 |
Cardiopulmonary bypass time (mins) | 1.0 | 0.9–1.1 | 0.40 |
b. Multivaraible model of risk factors associated with postoperative RHF | |||
---|---|---|---|
Variable | Adjusted Odds Ratio |
95% Confidence Interval | p-value |
Donor: Low-dose dopamine | 0.16 | 0.04–0.78 | 0.02 |
Donor: High-dose dopamine | 0.31 | 0.06–1.6 | 0.16 |
Recipient: Elevated Pre-operative PVRi (>6 WU × m2) | 4.0 | 1.4–11.9 | 0.01 |
Graft cold ischemic time (mins) | 0.99 | 0.98–1.0 | 0.40 |
Cardiopulmonary bypass time (mins) | 1.0 | 0.99–1.01 | 0.61 |
c: Reduced multivaraible model of risk factors associated with postoperative RHF | |||
---|---|---|---|
Variable | Adjusted Odds Ratio |
95% Confidence Interval | p-value |
Donor: Low-dose dopamine | 0.14 | 0.03–0.69 | 0.02 |
Donor: High-dose dopamine | 0.31 | 0.06–1.5 | 0.15 |
Recipient: Elevated Pre-operative PVRi (>6 WU × m2) | 5.1 | 1.8–14.5 | 0.002 |